Teladoc Health Analyst Price Targets - Benzinga

Teladoc Health Inc

TDOCNYSE

Trade with Public

Trade with Public

$9.41

-0.29-2.99%

Últ. Act.: Nov 5, 6:40 PM

Panorámica general Noticias Previsión de beneficios EventosPrecios objetivoFinanzas Sentimiento Propiedad Comparar Informe de acciones

Teladoc Health Analyst Price Targets

Wall Street analyst price targets and consensus rating for Teladoc Health (TDOC).

Price Target Range — 12 Quarters

Analyst Consensus — 21 Analysts

8Buy

13Hold

Consensus RatingNeutral# Analysts21Avg. Consensus PT$9Upside to Avg. PT+1.6%

Rating Trend — Last 9 Months

Recent Analyst Actions

Ver todas las valoraciones →

Date	Firm	Analyst	Action	Rating Change	Price Target
Nov 5, 2026	Wells Fargo	Stan Berenshteyn	PT Raise	Equal-Weight	$6→$8
Nov 4, 2026	Barclays	Glen Santangelo	PT Raise	Equal-Weight	$7→$9
Nov 2, 2026	UBS	Kevin Caliendo	PT Raise	Neutral	$7→$9
Nov 2, 2026	Oppenheimer	Michael Wiederhorn	PT Raise	Outperform	$7→$10
Oct 30, 2026	JP Morgan	Lisa Gill	PT Raise	Neutral	$8→$10
Oct 29, 2026	Stifel	David Grossman	PT Raise	Hold	$6→$7
Oct 29, 2026	Needham	Ryan MacDonald	Maintained	Hold	—
Aug 3, 2026	Citigroup	Daniel Grosslight	PT Cut	Neutral	$11→$8
Jul 30, 2026	Canaccord Genuity	Richard Close	PT Cut	Buy	$11→$10
Jul 30, 2026	Evercore ISI Group	Elizabeth Anderson	PT Cut	In-Line	$10→$8
Jul 21, 2026	Canaccord Genuity	Richard Close	PT Raise	Buy	$10→$11
Jul 7, 2026	B of A Securities	Allen Lutz	PT Raise	Buy	$9→$11
May 5, 2026	Citigroup	Daniel Grosslight	PT Raise	Neutral	$6→$7
Apr 8, 2026	Evercore ISI Group	Elizabeth Anderson	PT Raise	In-Line	$5→$6
Mar 26, 2026	Barclays	Glen Santangelo	PT Cut	Equal-Weight	$9→$7
Mar 13, 2026	JP Morgan	Lisa Gill	PT Cut	Neutral	$9→$7
Mar 10, 2026	B of A Securities	Allen Lutz	PT Raise	Buy	$7→$8
Mar 10, 2026	Deutsche Bank	George Hill	Upgrade	Hold→Buy	$11
Mar 3, 2026	Citigroup	Daniel Grosslight	PT Cut	Neutral	$9→$6
Mar 3, 2026	Oppenheimer	Michael Wiederhorn	PT Cut	Outperform	$12→$7

Analyst Ratings News

PRO
Wells Fargo Maintains Equal-Weight on Teladoc Health, Raises Price Target to $8

Wells Fargo analyst Stan Berenshteyn maintains Teladoc Health (NYSE:TDOC) with a Equal-Weight and raises the price target from $6 to $8.

Benzinga Newsdesk

PRO
Barclays Maintains Equal-Weight on Teladoc Health, Raises Price Target to $9

Barclays analyst Glen Santangelo maintains Teladoc Health (NYSE:TDOC) with a Equal-Weight and raises the price target from $7 to $9.

Benzinga Newsdesk

PRO
UBS Maintains Neutral on Teladoc Health, Raises Price Target to $9

UBS analyst Kevin Caliendo maintains Teladoc Health (NYSE:TDOC) with a Neutral and raises the price target from $6.5 to $9.

Benzinga Newsdesk

PRO
Oppenheimer Maintains Outperform on Teladoc Health, Raises Price Target to $10

Oppenheimer analyst Michael Wiederhorn maintains Teladoc Health (NYSE:TDOC) with a Outperform and raises the price target from $7 to $10.

Benzinga Newsdesk

PRO
JP Morgan Maintains Neutral on Teladoc Health, Raises Price Target to $10

JP Morgan analyst Lisa Gill maintains Teladoc Health (NYSE:TDOC) with a Neutral and raises the price target from $8 to $10.

Benzinga Newsdesk

PRO
Stifel Maintains Hold on Teladoc Health, Raises Price Target to $6.5

Stifel analyst David Grossman maintains Teladoc Health (NYSE:TDOC) with a Hold and raises the price target from $5.5 to $6.5.

Benzinga Newsdesk